Loading...
Thumbnail Image
Publication

Covariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinoma

Briggs, A
Daniele, B
Dick, K
Evans, TRJ
Galle, PR
Lopez, C
Siebert, U
Tremblay, G
Keywords
Type
Article
Citation
Briggs A, Daniele B, Dick K, Evans TRJ, Galle PR, Hubner RA, et al. Covariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinoma. Br J Cancer. 2020.
Journal Title
Journal ISSN
Volume Title
Embedded videos